Inhibitor of Apoptosis (IAP) Proteins–Modulators of Cell Death and Inflammation

  1. Pascal Meier2
  1. 1The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3052, Australia
  2. 2The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, Mary-Jean Mitchell Green Building, Chester Beatty Laboratories, London SW3 6JB, United Kingdom
  1. Correspondence: J.Silke{at}latrobe.edu.au; pmeier{at}icr.ac.uk

Abstract

Misregulated innate immune signaling and cell death form the basis of much human disease pathogenesis. Inhibitor of apoptosis (IAP) protein family members are frequently overexpressed in cancer and contribute to tumor cell survival, chemo-resistance, disease progression, and poor prognosis. Although best known for their ability to regulate caspases, IAPs also influence ubiquitin (Ub)-dependent pathways that modulate innate immune signaling via activation of nuclear factor κB (NF-κB). Recent research into IAP biology has unearthed unexpected roles for this group of proteins. In addition, the advances in our understanding of the molecular mechanisms that IAPs use to regulate cell death and innate immune responses have provided new insights into disease states and suggested novel intervention strategies. Here we review the functions assigned to those IAP proteins that act at the intersection of cell death regulation and inflammatory signaling.



Also in this Collection

      | Table of Contents

      In this Collection